About the company
Allergenix is a homegrown Saudi company bringing structured, AI-guided oral immunotherapy for food allergy to the Kingdom — a treatment pathway that is well established internationally but largely unavailable in the region.
The solution
Oral immunotherapy treats food allergy by introducing the allergen in precisely controlled, gradually increasing doses until the patient can tolerate accidental exposure without a severe reaction. It is one of the few interventions that addresses the allergy itself rather than managing its consequences.
The obstacle to wider use is that the protocol demands exact dose escalation and close clinical supervision over many months. Allergenix uses AI-guided protocol management to standardise dose progression, monitor patient response and flag reactions early — making the treatment deliverable safely at greater scale. For families, the outcome is a child who can attend school, eat out and travel without a constant risk of anaphylaxis.
What the KaRama VS team is doing
- Founded and incorporated the company within the Studio.
- Developing the clinical protocol and safety framework for delivery in the Kingdom.
- Engaging allergy and paediatric specialists at Kingdom centers.
- Mapping the regulatory pathway for treatment delivery.
- Preparing business plan, financial model and investor materials, and leading capital formation.
More in Biotech
KaRama Bio
Precision pediatric diagnosticsPrecision diagnostics for children's health, built and proven inside the Kingdom.
Linus Bio MENA
Exposome medicine · hair-based ASD detectionAutism spectrum disorder detected from a single strand of hair, as early as one month of age.
Medalign Arabia
AI robotic & AR surgical navigationRobotic and augmented-reality surgical navigation, precise to sub-millimetre accuracy.